Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Single-cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid during virologically suppressed HIV.

Farhadian SF, Mehta SS, Zografou C, Robertson K, Price RW, Pappalardo J, Chiarella J, Hafler DA, Spudich SS.

JCI Insight. 2018 Sep 20;3(18). pii: 121718. doi: 10.1172/jci.insight.121718. [Epub ahead of print]

2.

Epigenetic Changes of FKBP5 as a Link Connecting Genetic and Environmental Risk Factors with Structural and Functional Brain Changes in Major Depression.

Tozzi L, Farrell C, Booij L, Doolin K, Nemoda Z, Szyf M, Pomares FB, Chiarella J, O'Keane V, Frodl T.

Neuropsychopharmacology. 2018 Apr;43(5):1138-1145. doi: 10.1038/npp.2017.290. Epub 2017 Nov 28.

PMID:
29182159
3.

HIV Drug Resistance Mutations (DRMs) Detected by Deep Sequencing in Virologic Failure Subjects on Therapy from Hunan Province, China.

Chen X, Zou X, He J, Zheng J, Chiarella J, Kozal MJ.

PLoS One. 2016 Feb 19;11(2):e0149215. doi: 10.1371/journal.pone.0149215. eCollection 2016.

4.

Deep sequencing of HIV-1 variants from paired plasma and cerebrospinal fluid during primary HIV infection.

Gega A, Kozal MJ, Chiarella J, Lee E, Peterson J, Hecht FM, Liegler T, St John EP, Simen BB, Price RW, Spudich SS.

J Virus Erad. 2015;1(4):264-268.

5.

Impact of Early Environment on Children's Mental Health: Lessons From DNA Methylation Studies With Monozygotic Twins.

Chiarella J, Tremblay RE, Szyf M, Provençal N, Booij L.

Twin Res Hum Genet. 2015 Dec;18(6):623-34. doi: 10.1017/thg.2015.84. Epub 2015 Nov 26. Review.

PMID:
26608878
6.

Low-frequency NNRTI-resistant HIV-1 variants and relationship to mutational load in antiretroviral-naïve subjects.

Gupta S, Lataillade M, Kyriakides TC, Chiarella J, St John EP, Webb S, Moreno EA, Simen BB, Kozal MJ.

Viruses. 2014 Sep 16;6(9):3428-37. doi: 10.3390/v6093428.

7.

Prevalence of WHO transmitted drug resistance mutations by deep sequencing in antiretroviral-naïve subjects in Hunan Province, China.

Xiaobai Z, Xi C, Tian H, Williams AB, Wang H, He J, Zhen J, Chiarella J, Blake LA, Turenchalk G, Kozal MJ.

PLoS One. 2014 Jun 4;9(6):e98740. doi: 10.1371/journal.pone.0098740. eCollection 2014.

8.

Association between risk behaviors and antiretroviral resistance in HIV-infected patients receiving opioid agonist treatment.

Tetrault JM, Kozal MJ, Chiarella J, Sullivan LE, Dinh AT, Fiellin DA.

J Addict Med. 2013 Mar-Apr;7(2):102-7. doi: 10.1097/ADM.0b013e31827f9bdf.

9.

Virologic failures on initial boosted-PI regimen infrequently possess low-level variants with major PI resistance mutations by ultra-deep sequencing.

Lataillade M, Chiarella J, Yang R, DeGrosky M, Uy J, Seekins D, Simen B, St John E, Moreno E, Kozal M.

PLoS One. 2012;7(2):e30118. doi: 10.1371/journal.pone.0030118. Epub 2012 Feb 15.

10.

Prevalence of low-level HIV-1 variants with reverse transcriptase mutation K65R and the effect of antiretroviral drug exposure on variant levels.

Kozal MJ, Chiarella J, St John EP, Moreno EA, Simen BB, Arnold TE, Lataillade M.

Antivir Ther. 2011;16(6):925-9. doi: 10.3851/IMP1851.

PMID:
21900725
11.

Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-naïve subjects in the CASTLE study.

Lataillade M, Chiarella J, Yang R, Schnittman S, Wirtz V, Uy J, Seekins D, Krystal M, Mancini M, McGrath D, Simen B, Egholm M, Kozal M.

PLoS One. 2010 Jun 3;5(6):e10952. doi: 10.1371/journal.pone.0010952.

12.

Low-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral use.

Le T, Chiarella J, Simen BB, Hanczaruk B, Egholm M, Landry ML, Dieckhaus K, Rosen MI, Kozal MJ.

PLoS One. 2009 Jun 29;4(6):e6079. doi: 10.1371/journal.pone.0006079.

13.

Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance.

Lataillade M, Chiarella J, Kozal MJ.

Antivir Ther. 2007;12(4):563-70.

PMID:
17668566
14.

A population-based and longitudinal study of sexual behavior and multidrug-resistant HIV among patients in clinical care.

Kozal MJ, Amico KR, Chiarella J, Cornman D, Fisher W, Fisher J, Friedland G.

MedGenMed. 2006 Jun 13;8(2):72.

15.

HIV drug resistance and HIV transmission risk behaviors among active injection drug users.

Kozal MJ, Amico KR, Chiarella J, Cornman D, Fisher W, Fisher J, Friedland G.

J Acquir Immune Defic Syndr. 2005 Sep 1;40(1):106-9.

PMID:
16123691
16.

Antiretroviral resistance and high-risk transmission behavior among HIV-positive patients in clinical care.

Kozal MJ, Amico KR, Chiarella J, Schreibman T, Cornman D, Fisher W, Fisher J, Friedland G.

AIDS. 2004 Nov 5;18(16):2185-9.

PMID:
15577652
17.

Fair deal foiled by taxes and exchange rates.

Chiarella J.

Nature. 2004 Jun 10;429(6992):601. No abstract available.

PMID:
15190327
18.

Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2.

Bittencourt PL, Goldberg AC, Cançado EL, Porta G, Carrilho FJ, Farias AQ, Palacios SA, Chiarella JM, Abrantes-Lemos CP, Baggio VL, Laudanna AA, Kalil J.

Am J Gastroenterol. 1999 Jul;94(7):1906-13.

PMID:
10406258
19.

Absence of linkage between MHC and a gene involved in susceptibility to human schistosomiasis.

Chiarella JM, Goldberg AC, Abel L, Carvalho EM, Kalil J, Dessein A.

Braz J Med Biol Res. 1998 May;31(5):665-70.

PMID:
9698772
20.

HLA-DRB1*0405 is the predominant allele in Brazilian patients with Vogt-Koyanagi-Harada disease.

Goldberg AC, Yamamoto JH, Chiarella JM, Marin ML, Sibinelli M, Neufeld R, Hirata CE, Olivalves E, Kalil J.

Hum Immunol. 1998 Mar;59(3):183-8.

PMID:
9548078
21.

HLA class II antigens in rheumatic fever. Analysis of the DR locus by restriction fragment-length polymorphism and oligotyping.

Weidebach W, Goldberg AC, Chiarella JM, Guilherme L, Snitcowsky R, Pileggi F, Kalil J.

Hum Immunol. 1994 Aug;40(4):253-8.

PMID:
8002374
22.

Human leukocyte A and B antigen, gene and haplotype frequencies in the population of the city of São Paulo in Brazil.

Rosales T, Guilherme L, Chiarella J, Marin ML, Rosales C, Melo CP, Goldberg AC, Kalil J.

Braz J Med Biol Res. 1992;25(1):39-47.

PMID:
1304942
23.

The epidemiology of AIDS in the New York and California Medicaid programs.

Fanning TR, Cosler LE, Gallagher P, Chiarella J, Howell EM.

J Acquir Immune Defic Syndr. 1991;4(10):1025-35.

PMID:
1890597

Supplemental Content

Loading ...
Support Center